A5008340927- Diabetes Management and Research
- Cardiovascular Function and Risk Factors
- Diabetes and associated disorders
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Nutritional Studies and Diet
- Diet and metabolism studies
- Telemedicine and Telehealth Implementation
- Cancer, Hypoxia, and Metabolism
- COVID-19 and healthcare impacts
- Diabetes Management and Education
- Adrenal and Paraganglionic Tumors
- Pituitary Gland Disorders and Treatments
- Healthcare Systems and Technology
- Heart Rate Variability and Autonomic Control
- Pain Mechanisms and Treatments
- Inflammatory Biomarkers in Disease Prognosis
- Liver Disease Diagnosis and Treatment
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Disease and Adiposity
- Adipokines, Inflammation, and Metabolic Diseases
- Endoplasmic Reticulum Stress and Disease
Hospital Clínic de Barcelona
2021-2025
OBJECTIVE To evaluate the concordance between 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with EASD (ESC/EASD-2019) Steno T1 Risk Engine (Steno-Risk) risk scales for individuals type 1 diabetes (T1D) without disease (CVD) to analyze relationships of their use identification preclinical atherosclerosis. RESEARCH DESIGN AND METHODS We consecutively selected patients T1D, CVD, age ≥40 years, nephropathy, and/or ≥10 years T1D evolution...
People with type 1 diabetes (T1D) have an increased risk of cardiovascular disease (CVD). The Mediterranean diet is associated reduced CVD; however, the evidence in T1D scarce. We aimed to analyse relationships between adherence energy-restricted (erMEDd) and carotid atherosclerosis.
Since the arrival of continuous glucose monitoring (CGM), relationship between management indicator (GMI) and HbA1c has been a topic considerable interest in diabetes research. This study aims to explore association GMI/HbA1c ratio presence preclinical carotid atherosclerosis type 1 (T1D). Individuals with T1D no prior history cardiovascular disease were recruited from two centers. Carotid ultrasonography was performed using standardized protocol plaques defined as intima-media thickness ≥...
People with type 1 diabetes (T1D) have a high cardiovascular disease (CVD) risk, which remains the leading cause of death in this population. Despite improved control several classic risk factors, particularly better glycaemic control, morbidity and mortality continue to be significantly higher than general In routine clinical practice, estimating (CVR) people T1D using scales or equations is often imprecise because much evidence comes from pooled samples 2 (T2D) extrapolations studies...
Abstract Aims To explore the relationship between severe hypoglycemia (SH) and awareness with preclinical atherosclerosis in type 1 diabetes (T1D). Materials Methods Cross‐sectional study patients T1D without cardiovascular disease (CVD), ≥1 of following: ≥40 years, diabetic kidney disease, or ≥10 years duration another risk factor. CVD was estimated Steno T1 Risk Engine (Steno‐Risk). Carotid plaque evaluated using standardised ultrasonography protocol. Logistic regression models adjusted...
Cardiovascular disease (CVD) is the leading cause of mortality in type 1 diabetes (T1D). However, there a need for daily practice tools identifying those more prone to suffer from these events. We aimed assess relationships between nuclear magnetic resonance (1H NMR)-based lipidomic analysis and several CVD risk variables (including preclinical carotid atherosclerosis) individuals with T1D at high risk.We included patients without CVD, least one following: age ≥ 40 years, diabetic kidney...
Information about the impact of diabetic neuropathy (DN) on outcomes after pancreas transplantation (PT) is scarce. We assessed independent relationship between DN markers with both graft survival and incident cardiovascular disease (CVD) transplantation.A cohort study in individuals type 1 diabetes end-stage kidney who underwent PT 1999 2015 was conducted. vibration perception thresholds (VPTs) orthostatic hypotension (pre-PT 6 mo, 2-3, 5-6, 8-10 y transplantation). Pretransplantation...
The excess risk of fatal and nonfatal cardiovascular events is roughly twice as high in women than men with type 1 diabetes.
An increased midnight cortisol (MC) has been described in end-stage kidney disease (ESKD) and type 1 diabetes (T1D). Lower circulating levels of the cytokine soluble tumor necrosis factor (TNF)-like weak inducer apoptosis (sTWEAK) have found T1D ESKD associated with cardiovascular (CV) events latter. We aimed to study MC sTWEAK simultaneous pancreas-kidney transplant (SPKT) recipients, association these markers CV risk factors outcomes. This was a retrospective cohort including subjects who...
<p> </p> <p>Objective: To evaluate the concordance between ESC/EASD-2019 and Steno Type 1 Risk Engine (Steno-Risk) cardiovascular risk scales in persons with type diabetes (T1D) without disease (CVD), to analyze their relationships preclinical atherosclerosis. <p>Research design methods: We consecutively selected patients T1D, CVD, with: ≥40 years, nephropathy, or ≥10 years of evolution another factor. The presence plaque at different carotid segments was determined...
<p> </p> <p>Objective: To evaluate the concordance between ESC/EASD-2019 and Steno Type 1 Risk Engine (Steno-Risk) cardiovascular risk scales in persons with type diabetes (T1D) without disease (CVD), to analyze their relationships preclinical atherosclerosis. <p>Research design methods: We consecutively selected patients T1D, CVD, with: ≥40 years, nephropathy, or ≥10 years of evolution another factor. The presence plaque at different carotid segments was determined...
<p> </p> <p>Objective: To evaluate the concordance between ESC/EASD-2019 and Steno Type 1 Risk Engine (Steno-Risk) cardiovascular risk scales in persons with type diabetes (T1D) without disease (CVD), to analyze their relationships preclinical atherosclerosis. <p>Research design methods: We consecutively selected patients T1D, CVD, with: ≥40 years, nephropathy, or ≥10 years of evolution another factor. The presence plaque at different carotid segments was determined...